Literature DB >> 11728939

Orbital tumors.

R A Weisman1, D Kikkawa, K S Moe, J D Osguthorpe.   

Abstract

Neoplasms involving the orbit are divided into primary and secondary types. Primary orbital tumors are rare, include a wide variety of histopathologic types, are usually benign, and most often are managed surgically. Secondary orbital tumors are most often malignant, arise from the paranasal sinuses, and are managed with multiple modalities in a planned fashion. This article discusses primary and secondary orbital tumors, including their evaluation and management.

Entities:  

Mesh:

Year:  2001        PMID: 11728939     DOI: 10.1016/s0030-6665(05)70372-8

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  5 in total

Review 1.  Purely endoscopic trans-nasal management of orbital intraconal cavernous haemangiomas: a systematic review of the literature.

Authors:  Riccardo Lenzi; Benjamin S Bleier; Giovanni Felisati; Luca Muscatello
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-26       Impact factor: 2.503

2.  Surgical Anatomy of the Medial Wall of the Orbit in 14 Human Cadavers.

Authors:  Juan R Gras-Cabrerizo; Maria Martel-Martin; Jacinto Garcia-Lorenzo; Fernando Rodríguez-Álvarez; Joan R Montserrat-Gili; Rosa Mirapeix-Lucas; Humbert Massegur-Solench
Journal:  J Neurol Surg B Skull Base       Date:  2016-02-26

3.  Compartmental Endoscopic Surgical Anatomy of the Inferior Intraconal Orbital Space.

Authors:  Alice Z Maxfield; Christopher D Brook; Marcel M Miyake; Benjamin S Bleier
Journal:  J Neurol Surg B Skull Base       Date:  2017-09-04

4.  Transcranial surgery through pterional approach for removal of cranio-orbital tumors by an interdisciplinary team of nurosurgeons and ophthalmologists.

Authors:  Yan Liu; Jiang-Rong Ma; Xue-Liang Xu
Journal:  Int J Ophthalmol       Date:  2012-04-18       Impact factor: 1.779

Review 5.  Benign myoepithelioma of the lacrimal gland: report of a case.

Authors:  Andrea Bolzoni; Luca Pianta; Davide Farina; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-05-11       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.